Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD

NCT07654231 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease Mineral and Bone Disorder
Hypertension
Diabetes
Dyslipidemia
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (Stage 3)

Interventions

DRUG: Low-dose Colchicine at 0.5mg daily
OTHER: Usual Care

Sponsor

University of Texas Southwestern Medical Center